Trial Outcomes & Findings for Effects of Cognitive Behavioral Therapy on Brain Serotonin Activity in People With Depression (NCT NCT00641108)

NCT ID: NCT00641108

Last Updated: 2020-04-16

Results Overview

Recruitment status

COMPLETED

Study phase

PHASE2/PHASE3

Target enrollment

30 participants

Primary outcome timeframe

Measured at Weeks 0 and 12

Results posted on

2020-04-16

Participant Flow

The investigator has succumb to serious health issues which prevents him from physically inputting data in the system. The study team is no longer at the university and despite all efforts to contact them in order to enter data on the investigator's behalf, data are not available.

Participant milestones

Participant milestones
Measure
ADAM SPECT
Participants with depression will undergo ADAM SPECT scans and cognitive behavioral therapy. ADAM SPECT plus Cognitive Therapy
Control
Healthy subjects without depression will undergo ADAM SPECT scans. ADAM SPECT plus No Therapy
Overall Study
STARTED
0
0
Overall Study
COMPLETED
0
0
Overall Study
NOT COMPLETED
0
0

Reasons for withdrawal

Withdrawal data not reported

Baseline Characteristics

Effects of Cognitive Behavioral Therapy on Brain Serotonin Activity in People With Depression

Baseline characteristics by cohort

Baseline data not reported

PRIMARY outcome

Timeframe: Measured at Weeks 0 and 12

Population: The investigator has succumb to serious health issues which prevents him from physically inputting data in the system. The study team is no longer at the university and despite all efforts to contact them in order to enter data on the investigator's behalf, data are not available.

Outcome measures

Outcome data not reported

Adverse Events

ADAM SPECT

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Control

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Serious adverse events

Adverse event data not reported

Other adverse events

Adverse event data not reported

Additional Information

Tyrone Quarterman

University of Pennsylvania

Phone: 215-349-5537

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place